Infant Hospitalizations and Fatalities Averted by the Maternal Pertussis Vaccination Program in England, 2012-2017: Post-implementation Economic Evaluation.
Sandmann, Frank;
Jit, Mark;
Andrews, Nick;
Buckley, Hannah L;
Campbell, Helen;
Ribeiro, Sonia;
Sile, Bersabeh;
Stowe, Julia;
Tessier, Elise;
Ramsay, Mary;
+2 more...Choi, Yoon H;
Amirthalingam, Gayatri;
(2020)
Infant Hospitalizations and Fatalities Averted by the Maternal Pertussis Vaccination Program in England, 2012-2017: Post-implementation Economic Evaluation.
CLINICAL INFECTIOUS DISEASES, 71 (8).
pp. 1984-1987.
ISSN 1058-4838
DOI: https://doi.org/10.1093/cid/ciaa165
Permanent Identifier
Use this Digital Object Identifier when citing or linking to this resource.
In October 2012, a maternal pertussis vaccination program was implemented in England following an increased incidence and mortality in infants. We evaluated the cost-effectiveness of the program by comparing pertussis-related infant hospitalizations and deaths in 2012-2017 with nonvaccination scenarios. Despite considerable uncertainties, findings support the cost-effectiveness of the program.